These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 20425851)
1. The use of high resolution computerized tomography (HRCT) of the chest in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis lung disease. Nasr SZ; Sakmar E; Christodoulou E; Eckhardt BP; Streetman DS; Strouse PJ Pediatr Pulmonol; 2010 May; 45(5):440-9. PubMed ID: 20425851 [TBL] [Abstract][Full Text] [Related]
2. High resolution computerized tomography of the chest and pulmonary function testing in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis patients. Nasr SZ; Gordon D; Sakmar E; Yu X; Christodoulou E; Eckhardt BP; Strouse PJ Pediatr Pulmonol; 2006 Dec; 41(12):1129-37. PubMed ID: 17068818 [TBL] [Abstract][Full Text] [Related]
3. A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study. Chuchalin A; Csiszér E; Gyurkovics K; Bartnicka MT; Sands D; Kapranov N; Varoli G; Monici Preti PA; Mazurek H Paediatr Drugs; 2007; 9 Suppl 1():21-31. PubMed ID: 17536872 [TBL] [Abstract][Full Text] [Related]
4. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Barker AF; Couch L; Fiel SB; Gotfried MH; Ilowite J; Meyer KC; O'Donnell A; Sahn SA; Smith LJ; Stewart JO; Abuan T; Tully H; Van Dalfsen J; Wells CD; Quan J Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):481-5. PubMed ID: 10934074 [TBL] [Abstract][Full Text] [Related]
5. Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection. Quittner AL; Buu A Pediatr Pulmonol; 2002 Apr; 33(4):269-76. PubMed ID: 11921456 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis. Judge EP; Dodd JD; Masterson JB; Gallagher CG Chest; 2006 Nov; 130(5):1424-32. PubMed ID: 17099020 [TBL] [Abstract][Full Text] [Related]
7. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations. Al-Aloul M; Nazareth D; Walshaw M J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):299-305. PubMed ID: 24219814 [TBL] [Abstract][Full Text] [Related]
8. Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Lenoir G; Antypkin YG; Miano A; Moretti P; Zanda M; Varoli G; Monici Preti PA; Aryayev NL Paediatr Drugs; 2007; 9 Suppl 1():11-20. PubMed ID: 17536871 [TBL] [Abstract][Full Text] [Related]
9. Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease. Murphy TD; Anbar RD; Lester LA; Nasr SZ; Nickerson B; VanDevanter DR; Colin AA Pediatr Pulmonol; 2004 Oct; 38(4):314-20. PubMed ID: 15334509 [TBL] [Abstract][Full Text] [Related]
10. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641 [TBL] [Abstract][Full Text] [Related]
11. Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection. Greenwood J; Schwarz C; Sommerwerck U; Nash EF; Tamm M; Cao W; Mastoridis P; Debonnett L; Hamed K Ther Adv Respir Dis; 2017 Jul; 11(7):249-260. PubMed ID: 28614995 [TBL] [Abstract][Full Text] [Related]
12. High-resolution CT in the acute exacerbation of cystic fibrosis: evaluation of acute findings, reversibility of those findings, and clinical correlation. Shah RM; Sexauer W; Ostrum BJ; Fiel SB; Friedman AC AJR Am J Roentgenol; 1997 Aug; 169(2):375-80. PubMed ID: 9242738 [TBL] [Abstract][Full Text] [Related]
13. Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis. Moss RB Chest; 2002 Jan; 121(1):55-63. PubMed ID: 11796432 [TBL] [Abstract][Full Text] [Related]
14. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis. Cheer SM; Waugh J; Noble S Drugs; 2003; 63(22):2501-20. PubMed ID: 14609360 [TBL] [Abstract][Full Text] [Related]
15. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Bilton D; Henig N; Morrissey B; Gotfried M Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030 [TBL] [Abstract][Full Text] [Related]
16. A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis. Scheinberg P; Shore E Chest; 2005 Apr; 127(4):1420-6. PubMed ID: 15821224 [TBL] [Abstract][Full Text] [Related]
17. [New method of scoring lung changes using computed tomography in patients with cystic fibrosis]. Iwanowska B Med Wieku Rozwoj; 2012; 16(4):290-302. PubMed ID: 23378408 [TBL] [Abstract][Full Text] [Related]
18. Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: a preliminary study. Nasr SZ; Kuhns LR; Brown RW; Hurwitz ME; Sanders GM; Strouse PJ Pediatr Pulmonol; 2001 May; 31(5):377-82. PubMed ID: 11340684 [TBL] [Abstract][Full Text] [Related]
19. Economic impact of tobramycin in patients with cystic fibrosis in a managed care population. Wertz DA; Chang CL; Stephenson JJ; Zhang J; Kuhn RJ J Med Econ; 2011; 14(6):759-68. PubMed ID: 21942462 [TBL] [Abstract][Full Text] [Related]